Resource January 7, 2018 AMCP sends letter to Michigan House Health Policy Committee citing concerns with HB 4472 and regulations on pharmacists substituting interchangeable biological products AMCP comments on state legislation on substitution of interchangeable biologics. Formulary Management, Legislation & Regulation, Managed Care Practice Issues, Biosimilars, Legislation & Regulation
